Seeding trial

Content sourced from Wikipedia, licensed under CC BY-SA 3.0.

A seeding trial is a marketing or research experiment that targets a specific group of people to spread a product through word-of-mouth. There are two main kinds: seeding in marketing and seeding trials in medicine.

In marketing, seeding means giving a product or service to a chosen group (often early adopters or opinion leaders) to spark discussion and accelerate how quickly people learn about and want the product. The goal is to create buzz and faster adoption by turning testers into advocates who talk about the product with friends and colleagues. An early example is 3M’s Post-it notes: secretaries who received free samples suggested uses and became champions for the product.

In medicine, a seeding trial is a clinical study designed mainly to introduce a drug or device to doctors, not to answer a scientific question about the drug’s safety or effectiveness. Doctors and patients may get the drug for free, special information, and sometimes financial rewards or authorship on a publication. While not illegal, these trials are widely criticized as unethical because they hide the true marketing purpose and can undermine informed consent. They may also unduly influence doctors’ prescribing decisions.

Several famous cases have fueled these concerns. The ADVANTAGE trial connected to Vioxx and Naproxen raised questions about whether the study was really testing a science question or simply seeding doctors to use Vioxx. Pfizer’s STEPS trial, associated with Neurontin, also blended marketing with research. Courts and editors have criticized such practices and called for greater responsibility in separating science from marketing.

In marketing strategy, seeding involves deciding who to seed, how many people to reach, and where to seed. The aim is to trigger faster and broader adoption. Studies on seeding suggest that dispersing marketing efforts across many markets and audiences can be more effective than concentrating all effort in a few places. Concepts like the “sprinkler” model argue that spreading activity widely helps build a stronger overall impact.

Researchers have also looked at whether to seed through influencers or random customers. The idea, popularized by thinkers like Malcolm Gladwell, is that a small number of well-connected people can spark large trends. Some studies support influencer seeding as more valuable for long-term customer equity, while others find that random individuals can start trends just as effectively. The truth may depend on the product, market, and how the program is run.

In short, seeding can speed up product adoption and spread, but it must be used carefully. In medicine, it raises serious ethical issues and can compromise the integrity of science and patient consent. In marketing, it remains a powerful tool when designed transparently and aimed at genuine engagement rather than deceptive promotion.